United Therapeutics settles dispute with Liquidia Technologies
United Therapeutics and Liquidia Technologies have resolved their disclosed commercial-related disputes without admission of guilt. The settlement includes a mutual release regarding a non-NIH network systems vendor and acknowledges an Extradisciplinary action.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed